Infection Prevention Consultant IPC Consulting Group LLC Baltimore, Maryland
I do not have any relevant financial / non-financial relationships with any proprietary interests.
In 2019 Carbapenem-resistant Producing Enterobacterales (CPE) were identified as an urgent threat in the United States. Due to limited treatment options, CPE infections are associated with high morbidity and mortality. Due to the movement of patients throughout the healthcare system, if CPE are a problem in one facility, they are typically a problem in other facilities in the region.
A recent survey of infection prevention and antibiotic stewardship program needs and practices in 2021 conducted by the SHEA Research Network revealed that 39 of 50 (78%) of the facilities were performing surveillance for antibiotic-resistant gram-negative organisms. In this presentation, the speaker will discuss the current challenges with CPE for Infection Preventionists and how PCR testing can be used to enhance infection prevention programs in the hospital.
